Stockato

PL Due Diligence — Planet Labs PBC

Sam's full due-diligence report on PL (Planet Labs PBC) — verdict, conviction score, key metrics, and the signal behind it.

Sell4/10Mixed consensusPrice: $34.34Market cap: $17.1BRevenue (TTM): $308MProfit margin: -80%

$PL Due Diligence — Planet Labs PBC

Sell · 4/10 · Mixed consensus — full report on Stockato.

Price: $34.34
Market cap: $17.1B
Revenue (TTM): $308M
Profit margin: -80%

VERDICT: SELL
SCORE: 4/10
CONFIDENCE: MEDIUM — based on signal agreement

COMPANY OVERVIEW
Planet Labs PBC operates a constellation of Earth-observing satellites providing daily geospatial imagery and data analytics. The company serves agriculture, defense, intelligence, and commercial customers from the aerospace & defense sector with ~$308M TTM revenue.

KEY FUNDAMENTALS
Revenue TTM $307.7M (+41% YoY quarterly growth), gross margin 56%, EBITDA -$45M, EPS -$0.80. PS 55.7x, EV/Revenue 55.1x. Analyst consensus: 7 Buy / 3 Hold, $35.50 target (3% upside to $34.34). Short interest 11.5% of float, down 13% MoM. 52-week range $4.90–$51.76.

BULL CASE
- Q1 revenue beat with backlog +140% YoY to $527M and RPO +262% YoY to $452M.
- Defense/intel momentum plus 20%+ commercial growth; analysts raised targets to $49–$53 post-print.
- Management hit adjusted EBITDA breakeven milestone in FY2025 and raised FY2026 revenue guidance to $265–280M.
- Government satellite services deals (JSAT, Germany) provide multi-year visibility.

BEAR CASE
- $1.5B ATM equity offering filed immediately after earnings risks ~10% dilution at current prices.
- Stock fell 21.1% intraday to $34.34 on the filing despite the beat.
- Still unprofitable (operating margin -30%, ROE -78%) with thin FY2026 EBITDA guidance of only $0–10M.
- Valuation remains extreme at 55x sales while volume spiked 8x average on the sell-off.

OPTIONS POSITIONING (from full chain analysis)
Options snapshot is from the last regular session; full positioning will refresh on the next open.

X / SOCIAL CHATTER
Post-earnings chatter focused on the revenue beat and backlog surge but quickly turned to dilution risk from the $1.5B ATM. “A massive beat on revenue at $94.2M… backlog now over $906M” — @Kaizen_Investor. Analysts lifting targets to $53 were cited as bullish, yet multiple posts flagged the offering as near-term overhang. “The $1.5B ATM filing immediately after the print introduces near-term dilution” noted as the key contrarian view.

MANAGEMENT CREDIBILITY
8-quarter track record rated 7.5/10 with improving trajectory. Company delivered EBITDA breakeven and backlog growth but moved goalposts earlier on full-year guidance and booked repeated commercial headwinds. Recent quarters show cleaner execution and credible strategic pivot to AI-enabled services.

SIGNAL CROSS-CHECK
Price action and offering news conflict with bullish analyst raises and backlog metrics; technicals (price below 20/50 DMA, RSI 38) align with the 21% drop while X sentiment split between growth excitement and dilution concern.

KEY CATALYSTS
Q2 earnings (Aug 2026), first Owl satellite launch later this year, potential large government contract wins.

KEY RISKS
$1.5B ATM execution could pressure shares; continued cash burn and high valuation leave limited margin of safety if growth slows.

BOTTOM LINE
The 21% drop is a direct reaction to the $1.5B ATM filing that overshadows an otherwise strong Q1 beat. Near-term dilution risk outweighs upgraded targets for traders; wait for offering clarity before considering entry.